NCT03964558View on ClinicalTrials.gov

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430)

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

April 14, 2019

Study Completion Date

April 14, 2019

Conditions

Heathy Volunteers

Interventions

DRUG

[14C]-acebilustat solution

Acebilustat is a novel synthetic small molecule leukotriene A4 hydrolase (LTA4H) inhibitor.

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors

Lead Sponsor

Celtaxsys, Inc.

All Listed Sponsors

collaborator

Quotient Sciences

INDUSTRY

lead

Celtaxsys, Inc.

OTHER

NCT03964558 - Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430) | Biotech Hunter | Biotech Hunter